Extended Data Table 1 Participant characteristics at baseline of the 4-week BT run-in (week -4)

From: Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial

  1. Values are n(%) or means ± s.d. Early nonresponders are individuals who went on to lose <2% of baseline weight during the 4-week BT run-in, and early responders are those who lost ≥2%. *Five individuals were removed from the study in Phase 1 because they could not complete a randomization visit due to the suspension of in-person activities early in the COVID-19 pandemic. An additional 11 participants enrolled in phase 1 but were not included in phase 2 (3 did not complete a randomization visit because they were lost to follow-up, seven did not complete at least three treatment sessions in phase 1, and one declined randomization). BT, behavioral treatment; BP, blood pressure; BPM, beats per min; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PHQ-9, Patient Health Questionnaire-9; QOL, quality of life.
Back to article page